None listed
Conditions
Brief summary
Insomnia is a common disorder managed in Australian general practice. Insomnia can be effectively treated with online cognitive and behavioural therapy for insomnia (CBTi), which leads to long-lasting insomnia improvements. We aim to provide Australian GPs with access to an online CBTi program (Sleepio) to treat insomnia and reduce dependence on sleeping pills over time. It is hypothesised that patients referred to this trial of Sleepio will experience improved insomnia symptoms, and reduced sleeping pill use over time.
Interventions
This implementation trial will investigate the feasibility and effectiveness of providing Australian General Practitioners, and general practice patients access to online cognitive and behavioural therapy for insomnia (CBTi), and Royal Australian College of General Practitioner (RACGP) guideline recommendations on 'insomnia' management and 'sleeping pill withdrawal'. We will use existing General Practitioner software to identify three groups of patients, based on recent history of medications commonly prescribed for insomnia (including; Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone and Melatonin). We will divide patients into those with; 1. New Insomnia - No history of sleeping pills prescribed in the past 12 months, 2. Single Sleeping Pill Prescription - One sleeping pill prescription in the past 12 months 3. Repeat Sleeping Pill Prescriptions - Two or more sleeping pill prescriptions in the past 12 months Online CBTi will be made available to all three groups of patients. Sleepio (www.sleepio.com, Big Health, UK) is a well-established online CBTi program which includes 6-weekly self-administered sessions. Sleepio includes CBTi components; bedtime restriction therapy, stimulus control therapy, sleep hygiene information, relaxation therapy, and cognitive restructuring techniques. Patients may complete daily sleep diaries (3 min) in addition to weekly CBTi sessions (20-30 minutes each). Patients will receive reminder and summary emails to promote adherence throughout the program, however no additional support will be offered to encourage adherence. Via GP software, treating GPs will be sent notifications containing patient-tailored RACGP insomnia management guidelines and sleeping pill withdrawal information. These GP notifications will differ based on the above patient groups; 1. New Insomnia - GPs will receive a notification containing RACGP guidelines and a referral link to online CBTi, 2. Single Sleeping Pill Prescription - GPs will receive a notification containing RACGP guidelines, printable sleeping pill withdrawal fact sheets and tapering schedules, and a referral link to online CBTi, and 3. Repeat Sleeping Pill Prescriptions - GPs will receive a notification containing RACGP guidelines, printable sleeping pill withdrawal fact sheets and tapering schedules, and a referral link to online CBTi.
Sponsors
Study design
Eligibility
Inclusion criteria
General Practitioner Inclusion Criteria; 1. Currently using the Doctors Control Panel software Patient Inclusion Criteria 1. Age > 18 years. 2. Reliable access to computer, tablet or smartphone, with internet access 3. Basic English language comprehension as required for Sleepio. Group 1 "New Insomnia" - No GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months, Group 2 "Single Sleeping Pill Prescription" - One GP prescription of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months, Group 3 "Repeat Sleeping Pill Prescriptions" - Any combination of two or more GP prescriptions of Temazepam, Oxazepam, Nitrazepam, Zolpidem, Zopiclone, or Melatonin in the past 12 months.
Exclusion criteria
Patient Exclusion Criteria (assessed by treating GPs, according to RACGP/Sleepio recommendations); 1. Drug or alcohol problems 2. Terminal illness 3. Acute crisis 4. Risk of suicide 5. Severe mental illness 6. Organic brain disease 7. Epilepsy requiring benzodiazepine as part of anticonvulsant therapy 8. Benzodiazepine prescriptions for muscle spasms 9. Women who are currently pregnant Patient Exclusion Criteria (Assessed via online self-reported screening questionnaire): 1. Any previous diagnosis of Obstructive Sleep Apnea, Restless Legs Syndrome, or REM Behaviour Disorder.